About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID 		Itgb3
integrin beta 3
MGI:96612
83 phenotypes from 7 alleles in 8 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background		 Annotated Term Reference
\Itgb3tm1.1Wlbcr/\Itgb3tm1.1Wlbcr
involves: C57BL/6 		no abnormal phenotype detected J:224675
\Itgb3tm1Aja/\Itgb3tm1Aja
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 		abnormal platelet activation J:148306
abnormal platelet dense granule physiology J:148306
abnormal platelet physiology J:148306
decreased susceptibility to induced thrombosis J:148306
increased bleeding time J:148306
\Itgb3tm1Drp/\Itgb3tm1Drp
Not Specified 		abnormal blood coagulation J:73416
\Itgb3tm1Hyn/\Itgb3+
involves: 129S2/SvPas * C57BL/6 		cardiac hypertrophy J:119666
decreased heart rate J:119666
heart left ventricle hypertrophy J:119666
increased heart left ventricle weight J:119666
increased heart weight J:119666
increased response of heart to induced stress J:119666
\Itgb3tm1Hyn/\Itgb3tm1.1Wlbcr
\Lyz2tm1(cre)Ifo/\Lyz2+
involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 		abnormal osteoclast differentiation J:224675
abnormal osteoclast morphology J:224675
abnormal tumor pathology J:224675
abnormal tumor susceptibility J:224675
decreased collagen level J:224675
decreased osteoclast cell number J:224675
increased bone mineral density J:224675
increased trabecular bone volume J:224675
osteopetrosis J:224675
\Itgb3tm1Hyn/\Itgb3tm1.1Wlbcr
\Tg(Pf4-icre)Q3Rsko/0
involves: 129S2/SvPas * C57BL/6 		abnormal blood coagulation J:224675
abnormal hemostasis J:224675
decreased hemoglobin content J:224675
decreased platelet aggregation J:224675
enlarged spleen J:224675
gastrointestinal hemorrhage J:224675
increased bleeding time J:224675
intracranial hemorrhage J:224675
postnatal lethality, incomplete penetrance J:224675
\Itgb3tm1Hyn/\Itgb3tm1Hyn
involves: 129S2/SvPas 		abnormal osteoclast morphology J:60672
abnormal osteoclast physiology J:60672
abnormal physiological neovascularization J:96049
abnormal platelet physiology J:96049
decreased circulating calcium level J:60672
decreased keratinocyte proliferation J:96049
decreased macrophage cell number J:96049
enhanced wound healing J:96049
increased compact bone thickness J:60672
increased osteoclast cell number J:60672
increased trabecular bone thickness J:60672
increased transforming growth factor beta level J:96049
osteosclerosis J:60672
\Itgb3tm1Hyn/\Itgb3tm1Hyn
involves: 129S2/SvPas * BALB/c 		normal immune system phenotype J:131241
increased IgG level J:131241
increased miscarriage rate J:131241
maternal effect J:131241
pregnancy-related premature death J:131241
\Itgb3tm1Hyn/\Itgb3tm1Hyn
involves: 129S2/SvPas * C57BL/6 		abnormal cardiac muscle relaxation J:119666
abnormal cell adhesion J:73752
abnormal cell migration J:73752
abnormal induced retina neovascularization J:73752
abnormal macrophage physiology J:119666
abnormal placenta labyrinth morphology J:52262
abnormal platelet activation J:52262
abnormal trophoblast giant cell morphology J:52262
abnormal tumor vascularization J:73752
abnormal uterine environment J:52262
anemia J:52262
cardiac hypertrophy J:119666
decreased cardiac muscle contractility J:119666
decreased erythrocyte cell number J:52262
decreased heart rate J:119666
decreased hematocrit J:52262
decreased hemoglobin content J:52262
decreased left ventricle systolic pressure J:119666
dermatitis J:52262
enlarged spleen J:52262
extramedullary hematopoiesis J:52262
gastrointestinal hemorrhage J:52262
heart left ventricle hypertrophy J:119666
hemorrhage J:52262
hepatic necrosis J:52262
impaired macrophage chemotaxis J:119666
increased angiogenesis J:73752
increased bleeding time J:52262
increased heart left ventricle weight J:119666
increased heart weight J:119666
increased left ventricle diastolic pressure J:119666
increased miscarriage rate J:52262
increased monocyte cell number J:119666
increased response of heart to induced stress J:119666
increased tumor growth/size J:73752
myositis J:119666
pale placenta J:52262
petechiae J:52262
postnatal lethality, incomplete penetrance J:52262
premature death J:52262
purpura J:52262
reduced female fertility J:52262
renal necrosis J:52262
reticulocytosis J:52262
skin hemorrhage J:52262
uterine hemorrhage J:52262
normal vision/eye phenotype J:52262
\Itgb3tm1Mgin/\Itgb3tm1Mgin
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N 		abnormal platelet activation J:123968
decreased erythrocyte cell number J:123968
decreased hematocrit J:123968
decreased hemoglobin content J:123968
gastrointestinal hemorrhage J:123968
increased bleeding time J:123968
increased mean corpuscular hemoglobin J:123968
increased mean corpuscular volume J:123968
perinatal lethality, incomplete penetrance J:123968
\Itgb3tm2Aja/\Itgb3tm2Aja
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 		no abnormal phenotype detected J:148306
\Itgb3tm2Mgin/\Itgb3tm2Mgin
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N 		abnormal platelet activation J:123968
abnormal thrombosis J:129707
decreased erythrocyte cell number J:123968
gastrointestinal hemorrhage J:123968
increased bleeding time J:123968
increased mean corpuscular hemoglobin J:123968
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
03/25/2025
MGI 6.24 		The Jackson Laboratory